The cost of caring for chronic wounds in the US alone exceeds $50 billion and is greater than the five most costly forms of cancer.
We use our proprietary nanotechnology to solve some of the world’s toughest health challenges.
Beginning with the silent pandemic of wounds, our team is focused on improving healing outcomes through nanotechnology innovation.Contact Us
Healthcare Professionals are our Partners; Patients are our Common Purpose
NanoTess is a values-based, social enterprise with a vision to improve patient outcomes through nanotechnology innovation. Our company is focused on developing, validating, and commercializing nanomaterial platform technologies designed to solve some of the world's toughest health-related challenges and improve quality of life. By focusing on patient-first solutions, we offer cutting-edge technologies that bring value to all stakeholders.Learn More
Skin is the largest organ in the human body and one of the most complicated.
The skin has many roles in maintaining quality of life and health, but it is
also vulnerable when breached. ...
One type of chronic wound, diabetic foot ulcers, results in someone losing a limb every 20 seconds.
For those who undergo a lower limb amputation, nearly 70% will pass away within the next 5 years; a mortality rate second only to lung cancer.
It's statistics like these that drive our team to commercialize solutions to actively facilitate healing, reduce inflammation, and provide broad-spectrum infection protection. These attributes extend our potential impact beyond chronic wounds to acute and minor wounds, burns, surgical wounds, traumatic wounds, and skin tears, amongst other dermatological challenges.
The Potential of NANOKARE
Our Proprietary Technology
NANOKARE is a novel nano-structured material that is designed to effectively reduce the thresholds needed to achieve optimal healing outcomes, modulate healthy inflammation, and provide safe and effective broad-spectrum antimicrobial and biofilm protection. When deployed in an easy to apply and manage matrix gel, NANOKARE enables the power of our product NANOSALV Catalytic Advanced Wound Care Treatment Matrix.Learn More
NANOSALV Catalytic Advanced Wound Care Treatment Matrix
NANOSALV Catalytic Advanced Wound Care Treatment Matrix is a Health Canada approved Class II medical device indicated for the management and treatment of acute and chronic wounds, such as:
- Diabetic foot ulcers
- Pressure injuries
- Leg ulcers (venous stasis ulcers, arterial ulcers)
- Traumatic wounds
- Oncology wounds
- Surgical wounds
- Graft sites
- Donor sites
- Vascular access or peripheral intravenous sites
- Superficial wounds
- Minor cuts
- Minor skin infections
- Skin tears
- Irritated areas
CANADIAN MADE, GLOBALLY COMPASSIONATE
You help make NanoTess' social purpose a reality.
Your purchase supports limb saving research to improve patient outcomes through nanotechnology innovations.